Jens Ricke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jens Ricke has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
K.-J. Klose
Department of Radiology, Philips Universität, Marburg, Germany
2 shared publicationsRoland Felix
Department of Radiology, Charité Virchow-Klinikum, Medical Faculty, Humboldt University, Augustenburgerplatz 1, 13353 Berlin, Germany
2 shared publicationsArne Lemke
1 shared publicationB. Wiedenmann
Department of Hepatogastroenterology, Charité Campus Virchow-Klinikum, Medical Faculty, Humboldt University, Augustenburgerplatz 1, 13353 Berlin, Germany
1 shared publicationC Stroszczynski
Department of Radiology Charité, Campus Virchow-Klinikum, Humboldt-University Medical School, Augustenburgerplatz 1, 13353 Berlin, Germany
1 shared publicationC Zielinski
Department of Radiology Charité, Campus Virchow-Klinikum, Humboldt-University Medical School, Augustenburgerplatz 1, 13353 Berlin, Germany
1 shared publication
Latest Publications
- 1 May 2003
- Published by Springer Nature in European Radiology
- Vol. 13 (5) , 943-949
Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer
The purpose of this study was to assess the accuracy of MRI in the staging of intra-abdominal tumor seeding of ovarian carcinoma. Fifty-seven patients with suspected primary or recurrent ovarian carcinoma were included in this study. All patients received laparotomy within 8 weeks after MRI. The MRI protocol included fat-saturated T1-weighted spin-echo (SE) sequences pre- and post i.v. application of gadopentetate dimeglumine. The criteria for tumor manifestation was contrast enhancement of intra-abdominal soft tissue lesions or peritoneum. The image review was performed by a blinded radiologist, a specialist in gynecological and abdominal MR imaging. Results were compared with findings during laparotomy. Sensitivity, specificity, positive and negative predictive values, and corresponding 95% confidence intervals were calculated for single intra-abdominal locations and for groups of locations defined according to surgical strategies for intra-abdominal cytoreduction. Laparotomy and histopathology confirmed 251 abdominal tumor locations. Sensitivity was high in lower pelvis locations (73-83%) except for ureter or bladder infiltration (40%). Bowel or mesentery locations displayed sensitivity values from 73 to 77%. Sensitivity was very low for pelvic lymph nodes (28%), greater omentum (38%), and lesser sac (43%). Magnetic resonance imaging based on contrast-enhanced fat-saturated T1 SE sequences improves planning of cytoreduction preceding chemotherapy in advanced primary or relapsed ovarian carcinoma.
- 1 May 2003
- Published by Springer Nature in European Radiology
- Vol. 13 (5) , 943-949
Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer
The purpose of this study was to assess the accuracy of MRI in the staging of intra-abdominal tumor seeding of ovarian carcinoma. Fifty-seven patients with suspected primary or recurrent ovarian carcinoma were included in this study. All patients received laparotomy within 8 weeks after MRI. The MRI protocol included fat-saturated T1-weighted spin-echo (SE) sequences pre- and post i.v. application of gadopentetate dimeglumine. The criteria for tumor manifestation was contrast enhancement of intra-abdominal soft tissue lesions or peritoneum. The image review was performed by a blinded radiologist, a specialist in gynecological and abdominal MR imaging. Results were compared with findings during laparotomy. Sensitivity, specificity, positive and negative predictive values, and corresponding 95% confidence intervals were calculated for single intra-abdominal locations and for groups of locations defined according to surgical strategies for intra-abdominal cytoreduction. Laparotomy and histopathology confirmed 251 abdominal tumor locations. Sensitivity was high in lower pelvis locations (73-83%) except for ureter or bladder infiltration (40%). Bowel or mesentery locations displayed sensitivity values from 73 to 77%. Sensitivity was very low for pelvic lymph nodes (28%), greater omentum (38%), and lesser sac (43%). Magnetic resonance imaging based on contrast-enhanced fat-saturated T1 SE sequences improves planning of cytoreduction preceding chemotherapy in advanced primary or relapsed ovarian carcinoma.
- 1 January 2001
- Published by Elsevier in European Journal of Radiology
- Vol. 37 (1) , 8-17
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process
- 1 January 2001
- Published by Elsevier in European Journal of Radiology
- Vol. 37 (1) , 8-17
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process
- 1 July 2000
- Published by S. Karger AG in Digestion
- Vol. 62 (Suppl. 1) , 39-44
Imaging Procedures in Neuroendocrine Tumours
Purpose: To give recommendations for diagnostic imaging workflow in suspected neuroendocrine tumours. Materials and Methods: Recommendations for imaging workflow were elaborated by consensus of researchers in neuroendocrine tumours. Results: Workflow charts are presented for: (1) nonfunctional and functional endocrine tumours of the pancreas (except insulinoma); (2) insulinoma; (3) ECL cell tumour; (4) assessment of unknown primaries in functional and nonfunctional neuroendocrine tumours of the gut; (5) assessment of metastases in functional and nonfunctional neuroendocrine tumours of the gut. Conclusions: The workflow charts facilitate diagnosis of neuroendocrine tumours as well as the design of controlled studies.
- 1 July 2000
- Published by S. Karger AG in Digestion
- Vol. 62 (Suppl. 1) , 39-44
Imaging Procedures in Neuroendocrine Tumours
Purpose: To give recommendations for diagnostic imaging workflow in suspected neuroendocrine tumours. Materials and Methods: Recommendations for imaging workflow were elaborated by consensus of researchers in neuroendocrine tumours. Results: Workflow charts are presented for: (1) nonfunctional and functional endocrine tumours of the pancreas (except insulinoma); (2) insulinoma; (3) ECL cell tumour; (4) assessment of unknown primaries in functional and nonfunctional neuroendocrine tumours of the gut; (5) assessment of metastases in functional and nonfunctional neuroendocrine tumours of the gut. Conclusions: The workflow charts facilitate diagnosis of neuroendocrine tumours as well as the design of controlled studies.
- 1 May 2000
- Published by Elsevier in European Journal of Cancer
- Vol. 36 (7) , 826-833
Telemedicine and its impact on cancer management
- 1 May 2000
- Published by Elsevier in European Journal of Cancer
- Vol. 36 (7) , 826-833
Telemedicine and its impact on cancer management
- 1 April 2000
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 35 (4) , 253-259
Assessment of the Vascularization of Neuroendocrine Tumors by Stimulated Acoustic Emission of SH U 508A Ultrasound Contrast Agent and Color or Power Doppler Sonography
Ricke J, Lopez Hänninen E, Amthauer H, Lemke A, Felix R. Assessment of the vascularization of neuroendocrine tumors by stimulated acoustic emission of SH U 508A ultrasound contrast agent and color or power Doppler sonography. Invest Radiol 2000;35:253–259. To assess the vascularization of neuroendocrine tumors by stimulated acoustic emission (SAE) of SH U 508A during the blood pool phase in comparison with contrast-enhanced Doppler sonography. Thirty-six patients with neuroendocrine tumors received contrast-enhanced Doppler sonography and 21, an additional SAE. To classify tumor perfusion on Doppler sonography, a 4-step rating score was introduced: (1) no vessels (hypoperfusion); (2) one feeding or central vessel (hypoperfusion); (3) some vessels (hyperperfusion); and (4) disseminated vessels (hyperperfusion). In 36 patients, 1 pancreatic primary tumor, 33 liver metastases, 1 splenic metastasis, and 1 lymph node metastasis were examined. Results were correlated with biphasic spiral CT (n = 35) and angiography (n = 2). Arterial-phase CT and digital subtraction angiography revealed 18 hyper- and 18 hypoperfused lesions. Contrast-enhanced Doppler correctly classified 15 of 18 patients (83%) with hyperperfused lesions as well as 16 of 18 (89%) hypoperfused tumors by applying the rating score. SAE correctly identified 4 of 9 hyperperfused lesions (44%), 2 were isoperfused compared with normal liver tissue (22%), and 3 were hypoperfused (33%). Of 12 hypoperfused lesions, 11 were classified correctly (92%), and 1 showed isoperfusion. Hence, the positive and negative predictive values for SAE were 80% and 69%, respectively. For contrast-enhanced Doppler sonography, positive and negative predictive values were 88% and 84%, respectively. Blood pool SAE failed to determine subtle tumor perfusion correctly. The rating score for contrast-enhanced Doppler sonography characterized tumor perfusion with high accuracy. The use of a contrast agent significantly improved perfusion characterization.
- 1 April 2000
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 35 (4) , 253-259
Assessment of the Vascularization of Neuroendocrine Tumors by Stimulated Acoustic Emission of SH U 508A Ultrasound Contrast Agent and Color or Power Doppler Sonography
Ricke J, Lopez Hänninen E, Amthauer H, Lemke A, Felix R. Assessment of the vascularization of neuroendocrine tumors by stimulated acoustic emission of SH U 508A ultrasound contrast agent and color or power Doppler sonography. Invest Radiol 2000;35:253–259. To assess the vascularization of neuroendocrine tumors by stimulated acoustic emission (SAE) of SH U 508A during the blood pool phase in comparison with contrast-enhanced Doppler sonography. Thirty-six patients with neuroendocrine tumors received contrast-enhanced Doppler sonography and 21, an additional SAE. To classify tumor perfusion on Doppler sonography, a 4-step rating score was introduced: (1) no vessels (hypoperfusion); (2) one feeding or central vessel (hypoperfusion); (3) some vessels (hyperperfusion); and (4) disseminated vessels (hyperperfusion). In 36 patients, 1 pancreatic primary tumor, 33 liver metastases, 1 splenic metastasis, and 1 lymph node metastasis were examined. Results were correlated with biphasic spiral CT (n = 35) and angiography (n = 2). Arterial-phase CT and digital subtraction angiography revealed 18 hyper- and 18 hypoperfused lesions. Contrast-enhanced Doppler correctly classified 15 of 18 patients (83%) with hyperperfused lesions as well as 16 of 18 (89%) hypoperfused tumors by applying the rating score. SAE correctly identified 4 of 9 hyperperfused lesions (44%), 2 were isoperfused compared with normal liver tissue (22%), and 3 were hypoperfused (33%). Of 12 hypoperfused lesions, 11 were classified correctly (92%), and 1 showed isoperfusion. Hence, the positive and negative predictive values for SAE were 80% and 69%, respectively. For contrast-enhanced Doppler sonography, positive and negative predictive values were 88% and 84%, respectively. Blood pool SAE failed to determine subtle tumor perfusion correctly. The rating score for contrast-enhanced Doppler sonography characterized tumor perfusion with high accuracy. The use of a contrast agent significantly improved perfusion characterization.
- 21 February 2000
- Published by Elsevier in Computerized Medical Imaging and Graphics
- Vol. 24 (1) , 25-32
Shortcomings of low-cost imaging systems for viewing computed radiographs
- 21 February 2000
- Published by Elsevier in Computerized Medical Imaging and Graphics
- Vol. 24 (1) , 25-32
Shortcomings of low-cost imaging systems for viewing computed radiographs
- 31 December 1999
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 171 (6) , 461-467
Fettsaturierte kontrastverstärkte Spin-Echo-Sequenzen in der magnetresonanz-tomographischen Diagnostik der Peritonealkarzinose
Ziel: Evaluierung von kontrastverstärkten Spin-Echo-Sequenzen in Verbindung mit frequenz-selektiven Fettsättigungsimpulsen für die Detektion von Peritonealkarzinosen in der MRT. Material und Methode: 61 Patienten, davon 35 mit gesicherter und 26 ohne Peritonealkarzinose, wurden einer abdominellen MRT mit fettsaturierten, T1-gewichteten Spin-Echo-Sequenzen vor und nach Applikation von Gd-DTPA zugeführt. 22 der Patienten mit Peritonealkarzinose wurden darüber hinaus mittels kontrastmittelgestützter CT untersucht. Ergebnisse: 32/35 Patienten mit Peritonealkarzinose zeigten in der MRT eine Kontrastmittelanreicherung von Darmwänden oder des viszeralen, 30/35 des parietalen Peritoneums (91 und 86 %). Verdickung von Darmwänden oder parietalem Peritoneum zeigten 21 bzw. 20/35 (60 % bzw. 57 %), Aszites 18/35 Patienten (51 %). Falsch-positives Enhancement von Peritoneum boten 4/26 Patienten (15 %). Im direkten Vergleich der MRT mit der CT zeigten 22/22 bzw. 7/22 Patienten Enhancement viszeralen Peritoneums (100 % bzw. 32 %). Die sonstigen Hinweise auf eine Peritonealkarzinose (z. B. Aszites, peritoneale Raumforderung) wurden in gleichem Maße erkannt. Schlußfolgerung: Die fettsaturierte Spin-Echo-Sequenz ist durch Artefaktreduktion und die verbesserte Detektion peritonealer Kontrastmittelanreicherung hilfreich bei der Diagnose von Peritonealkarzinosen. Bei dieser Fragestellung zeigte sich die um fettsaturierte Spin-Echo-Sequenzen ergänzte MRT der CT überlegen. Purpose: To evaluate contrast-enhanced, fat-saturated spin echo sequences for the detection of peritoneal carcinosis with MRI. Materials and Methods: 61 patients, 35 with and 26 without peritoneal carcinosis, were examined with abdominal MRI. Fat-saturated, T1-weighted spin echo sequences were performed before and after administration of Gd-DTPA. In addition, 22 patients with peritoneal carcinosis were examined with contrast-enhanced abdominal CT. Results: 32 of 35 patients with peritoneal carcinosis demonstrated contrast enhancement of the visceral and 30 of 35 enhancement of the parietal peritoneum (91 and 86 %, respectively). Wall thickening of the intestine or parietal peritoneum were noted in 21 and 20 of 35 patients (60 and 57 %, respectively), ascites in 18 of 35 patients (51 %). False positive contrast enhancement of the peritoneum was noted in 4 of 26 patients (15 %). In the direct comparison of MRI and CT, 22 of 22 patients versus 7 of 22 patients showed contrast enhancement of the visceral peritoneum (100 and 32 %, respectively). For other signs of peritoneal carcinosis (e. g., ascites, peritoneal seedings), no differences in diagnostic reliability were demonstrated. Conclusions: The use of fat-saturated, spin echo sequences facilitates the diagnosis of peritoneal carcinosis by artifact reduction and improved detection of peritoneal contrast enhancement. MRI with fat-saturated sequences was superior to CT.
- 31 December 1999
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 171 (6) , 461-467
Fettsaturierte kontrastverstärkte Spin-Echo-Sequenzen in der magnetresonanz-tomographischen Diagnostik der Peritonealkarzinose
Ziel: Evaluierung von kontrastverstärkten Spin-Echo-Sequenzen in Verbindung mit frequenz-selektiven Fettsättigungsimpulsen für die Detektion von Peritonealkarzinosen in der MRT. Material und Methode: 61 Patienten, davon 35 mit gesicherter und 26 ohne Peritonealkarzinose, wurden einer abdominellen MRT mit fettsaturierten, T1-gewichteten Spin-Echo-Sequenzen vor und nach Applikation von Gd-DTPA zugeführt. 22 der Patienten mit Peritonealkarzinose wurden darüber hinaus mittels kontrastmittelgestützter CT untersucht. Ergebnisse: 32/35 Patienten mit Peritonealkarzinose zeigten in der MRT eine Kontrastmittelanreicherung von Darmwänden oder des viszeralen, 30/35 des parietalen Peritoneums (91 und 86 %). Verdickung von Darmwänden oder parietalem Peritoneum zeigten 21 bzw. 20/35 (60 % bzw. 57 %), Aszites 18/35 Patienten (51 %). Falsch-positives Enhancement von Peritoneum boten 4/26 Patienten (15 %). Im direkten Vergleich der MRT mit der CT zeigten 22/22 bzw. 7/22 Patienten Enhancement viszeralen Peritoneums (100 % bzw. 32 %). Die sonstigen Hinweise auf eine Peritonealkarzinose (z. B. Aszites, peritoneale Raumforderung) wurden in gleichem Maße erkannt. Schlußfolgerung: Die fettsaturierte Spin-Echo-Sequenz ist durch Artefaktreduktion und die verbesserte Detektion peritonealer Kontrastmittelanreicherung hilfreich bei der Diagnose von Peritonealkarzinosen. Bei dieser Fragestellung zeigte sich die um fettsaturierte Spin-Echo-Sequenzen ergänzte MRT der CT überlegen. Purpose: To evaluate contrast-enhanced, fat-saturated spin echo sequences for the detection of peritoneal carcinosis with MRI. Materials and Methods: 61 patients, 35 with and 26 without peritoneal carcinosis, were examined with abdominal MRI. Fat-saturated, T1-weighted spin echo sequences were performed before and after administration of Gd-DTPA. In addition, 22 patients with peritoneal carcinosis were examined with contrast-enhanced abdominal CT. Results: 32 of 35 patients with peritoneal carcinosis demonstrated contrast enhancement of the visceral and 30 of 35 enhancement of the parietal peritoneum (91 and 86 %, respectively). Wall thickening of the intestine or parietal peritoneum were noted in 21 and 20 of 35 patients (60 and 57 %, respectively), ascites in 18 of 35 patients (51 %). False positive contrast enhancement of the peritoneum was noted in 4 of 26 patients (15 %). In the direct comparison of MRI and CT, 22 of 22 patients versus 7 of 22 patients showed contrast enhancement of the visceral peritoneum (100 and 32 %, respectively). For other signs of peritoneal carcinosis (e. g., ascites, peritoneal seedings), no differences in diagnostic reliability were demonstrated. Conclusions: The use of fat-saturated, spin echo sequences facilitates the diagnosis of peritoneal carcinosis by artifact reduction and improved detection of peritoneal contrast enhancement. MRI with fat-saturated sequences was superior to CT.